In short
This article discusses clinical trials investigating the use of Dermatophagoides Pteronyssinus Extract, a substance derived from house dust mites, in the treatment of allergies. These trials aim to evaluate the safety and effectiveness of various immunotherapy approaches using this extract for patients with allergic conditions such as rhinitis, rhinoconjunctivitis, and asthma.
At a glance
- Study Type
- Phase II-III clinical trials
- Main Objective
- Evaluate efficacy and safety of immunotherapy using Dermatophagoides Pteronyssinus Extract
- Target Conditions
- Moderate-to-severe allergic rhinitis/rhinoconjunctivitis, with or without mild-to-moderate controlled asthma
- Administration Methods
- Sublingual immunotherapy, skin-prick tests
- Primary Endpoint
- Combined Symptom and Medication Score (CSMS) during peak allergy periods
- Key Inclusion Criteria
- Adults 18-65, confirmed house dust mite allergy, moderate-to-severe symptoms
- Key Exclusion Criteria
- Recent immunotherapy, severe asthma, certain medical conditions, pregnancy
- Safety Assessments
- Monitoring of adverse events, tolerability of treatment
What is DERMATOPHAGOIDES PTERONYSSINUS EXTRACT?
DERMATOPHAGOIDES PTERONYSSINUS EXTRACT is a medical product derived from house dust mites, specifically the species Dermatophagoides pteronyssinus. This extract is used in both diagnostic and therapeutic applications for allergies related to house dust mites. It's important to note that this extract is considered a structurally diverse substance - allergen, meaning it contains various components that can trigger allergic responses in sensitive individuals.
What Conditions Does It Treat?
DERMATOPHAGOIDES PTERONYSSINUS EXTRACT is primarily used to diagnose and treat allergic conditions caused by house dust mites. These conditions include:
- Allergic rhinitis (hay fever): Inflammation of the nasal passages causing symptoms like sneezing, runny nose, and nasal congestion
- Allergic rhinoconjunctivitis: A condition affecting both the nose and eyes, causing symptoms in both areas
- Allergic asthma: A type of asthma triggered by allergens, in this case, house dust mites
These conditions can range from moderate to severe and significantly impact a person's quality of life.
How Does It Work?
DERMATOPHAGOIDES PTERONYSSINUS EXTRACT works through a process called immunotherapy. When used therapeutically, small amounts of the allergen are introduced to the patient's body, gradually increasing over time. This helps the immune system build tolerance to the allergen, reducing allergic reactions when exposed to house dust mites in everyday life.
In diagnostic applications, the extract is used to identify if a person is allergic to house dust mites. This is typically done through skin prick tests or by measuring specific IgE antibodies in the blood.
How is It Administered?
DERMATOPHAGOIDES PTERONYSSINUS EXTRACT can be administered in several ways:
- Skin Prick Test: For diagnostic purposes, a drop of the solution is placed on the skin, which is then pricked. A positive reaction indicates an allergy.
- Sublingual Immunotherapy (SLIT): The extract is placed under the tongue as drops or tablets for treatment purposes.
- Subcutaneous Immunotherapy (SCIT): The extract is injected under the skin in gradually increasing doses.
Effectiveness
Clinical trials have shown that immunotherapy with DERMATOPHAGOIDES PTERONYSSINUS EXTRACT can be effective in reducing symptoms of allergic rhinitis, rhinoconjunctivitis, and allergic asthma. The effectiveness is often measured using scales such as the Combined Symptom and Medication Score (CSMS), which takes into account both the severity of symptoms and the need for rescue medication.
Potential Side Effects and Safety Considerations
While generally considered safe when used as directed, DERMATOPHAGOIDES PTERONYSSINUS EXTRACT can cause side effects, including:
- Local reactions at the site of administration (redness, swelling, itching)
- Mild systemic reactions (sneezing, runny nose)
- In rare cases, more severe allergic reactions
It's crucial to use this treatment under medical supervision, especially for individuals with severe asthma or other significant health conditions.
Who Can Use This Treatment?
DERMATOPHAGOIDES PTERONYSSINUS EXTRACT is typically used for:
- Individuals aged 12-65 with confirmed allergy to house dust mites
- Patients with moderate to severe allergic rhinitis or rhinoconjunctivitis
- Those with well-controlled mild to moderate allergic asthma
However, it may not be suitable for everyone. Contraindications include severe or uncontrolled asthma, certain immune system disorders, and ongoing treatment with certain medications.
Current Clinical Trials
Several clinical trials are ongoing to further investigate the efficacy and safety of DERMATOPHAGOIDES PTERONYSSINUS EXTRACT and similar allergen extracts. These studies aim to optimize dosing, evaluate long-term effects, and compare different administration methods. Patients interested in participating in such trials should consult with their healthcare provider for more information.